Journal of Bone and Mineral Research

publication venue for

Characterizing a Rodent Model of Lipopolysaccharide Induced Bone Loss: A Systematic-Review and Meta-analysis 2023
One- and five-year survival after fragility fracture: Real-world retrospective matched-cohort study in Ontario, Canada 2023
Burden of Paget's Disease of Bone: Temporal Trend Over 20 years in Quebec, Canada 2022
Development of a Convolutional Neural Network for the Automated Identification of Vertebral Compression Fractures in Hologic Vertebral Fracture Assessment Images using Active Learning 2022
Development of a Convolutional Neural Network for the Automated Identification of Vertebral Compression Fractures in Hologic Vertebral Fracture Assessment Images using Active Learning 2022
Guidelines on Diagnosis, Evaluation and Management of Hypoparathyroidism:2021 2022
Guidelines on Diagnosis, Evaluation, and Management of Primary Hyperparathyroidism, 2021 2022
The association between cognitive impairment, frailty, and history of falls and self-reported new fractures in the last year: results from the Canadian Longitudinal Study on Aging (CLSA) 2022
Vibration in Preventing Breast Cancer Bone Metastasis 2022
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease 2020
An overview of the etiology, clinical manifestations, management strategies and complications of hypoparathyroidism from the Canadian National Hypoparathyroidism Registry 2020
Development of an Electrical Stimulation Environment for Osteocytes 2020
Efficacy of low dose Denosumab in maintaining bone mineral density in postmenopausal women with osteoporosis: a real world, prospective observational study 2020
The Fragility Hip Fracture: Not only a Marked Burden of Disease, but also a Significant Predictor of Subsequent Hip Fracture Risk 2020
An Overview of the Etiology, Clinical Manifestations, Management Strategies, and Complications of Hypoparathyroidism from the Canadian National Hypoparathyroidism Registry 2019
An Overview of the Etiology, Clinical Manifestations, Management Strategies, and Complications of Hypoparathyroidism from the Canadian National Hypoparathyroidism Registry 2019
Exploring the Association Between Vertebral Fracture Characteristics and Pain 2019
Frailty In Combination With Trabecular Bone Score For Enhancing Predictive Accuracy Of Major Osteoporotic Fracture Risk 2019
Frailty In Combination With Trabecular Bone Score For Enhancing Predictive Accuracy Of Major Osteoporotic Fracture Risk 2019
Greater Fear of Falling is associated with Lower Exercise Self-efficacy in Older Women with Vertebral Fractures. 2019
Greater Fear of Falling is associated with Lower Exercise Self-efficacy in Older Women with Vertebral Fractures. 2019
REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA 2019
REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA 2019
Real-World Outcomes and Imminent Fractures After Index Fragility Fracture: A Population Study 2019
Real-World Outcomes and Imminent Fractures After Index Fragility Fracture: A Population Study 2019
Tool for estimating risk of Atypical Femur Fractures 2019
An overview of the etiology, clinical manifestations, management strategies and complications of hypoparathyroidism from the Canadian National Hypoparathyroidism Registry 2018
Effect of Home Exercise on Functional Performance, Posture, Quality of Life and Pain in Older Women with Vertebral Fractures: A Pilot Feasibility Trial 2018
The Long-term Impact of Incident Low-trauma Fractures on Health-related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study 2018
Trunk Muscle Endurance in Women with Osteoporotic Vertebral Fractures: an Exploratory Analysis from a Pilot Randomized Controlled Trial 2018
A Multifaceted Intervention Improves Functional Fitness in Pre-frail/frail Seniors: Results from the TAPESTRY-TRIAGE Study. 2017
A Whole Genome Association Meta-Analysis Study Identifies Novel Loci Associated with Bone Microarchitecture Assessed by HR-pQCT independent of aBMD. 2017
An overview of the etiology, clinical manifestations, management strategies and complications of hypoparathyroidism from the Canadian National Hypoparathyroidism Registry (CNHR). 2017
Are grade 1 vertebral fracture, fractures? 2017
Associations of Cognitive Dietary Restraint with Changes in Body Mass Index and Bone Mineral Density: A Population-based Cohort Study of Premenopausal Women and Men Aged 25-49 Years from CaMos. 2017
Build better bones with exercise: feasibility of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture. 2017
Comparisons of Hip Fractures Rates for a New Fracture Risk Scale in Adults Living in Long-term Care Across Canada. 2017
Continued Fracture Risk Reduction After 12 Months of Romosozumab Followed by Denosumab Through 36 Months in the Phase 3 FRAME (FRActure study in postmenopausal woMen with ostEoporosis) Extension. 2017
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk among Oral Glucocorticoid Users. 2017
Examining the Longitudinal Changes in Trabecular vBMD in Individuals with a Chronic SCI. 2017
Hyperelastic Bone Composite: A Novel 3D-printed Biomaterial Ink used for Spinal Fusion. 2017
Prediction of Incident Fragility Fractures in Women with Peripheral CT Imaging - One Slice is Often Enough: the CaMos Bone Quality Study 2017
Testing an Evidence-based Theoretical Model of Imminent (1-year) Fracture Risk in Elderly Women: Results from the Canadian Multicentre Osteoporosis Study (CaMOS). 2017
Transition to re-fracture and mortality in the elderly: An individualized risk assessment tool for fracture and its outcomes from two large population-based prospective cohort studies. 2017
Direct and Indirect Effects of Frailty on Fractures: Potential Roles of Muscle and Bone. 2014
Evolution of Subject Characteristics in FREEDOM and its Extension for Up to 8 Years. 2014
How Does the Frailty Status of a Population- based Cohort Change? Results from the Longitudinal Canadian Multicentre Osteoporosis Study (CaMos). 2014
Long-term Changes in Bone Mineral Density in Kidney Transplant Recipients. 2014
Long-term Improvements in Bone Mineral Density and Health Related Quality of Life in Osteoporosis Patients Treated with Teriparatide. 2014
Longitudinal Changes in Distal Lower-Extremity Muscle Area and Density after Chronic Spinal Cord Injury. 2014
Low Rate of Osteoporosis Treatment in Nursing Home Men at High-risk for Fractures 2014
Lower Extremity Muscle Size, Density and Function Is Associated with Indices of Bone Quality in Individuals with Chronic Spinal Cord Injury. 2014
Macro- and Microstructural Outcomes of Leg Muscle and Bone are Similar in Postmenopausal Women With and Without Osteoporosis 2014
Nutrition and Physical Activity Determinants of Muscle Adiposity and Bone Density Measured by MRI and pQCT 2014
Persistence With Prolia (R) (Denosumab) for 1 Year in Relation to Patient-reported Data: Interim Results From a Prospective Observational Study of Postmenopausal Women With Osteoporosis. 2014
Phosphaturic Mesenchymal Tumour (PMT) of the Ethmoid Sinus, Confirmed with Chromogenic In-Situ Hybridization for FGF23 2014
Supplementation with Beetroot Juice Does Not Affect Bone Microarchitecture of the Femur or Lumbar Vertebrae of OVX Rats. 2014
Testosterone and its derivatives for the treatment of Sarcopenia in elderly males: A systematic review and Meta-analysis. 2014
The Choice of Pediatric Reference Database Changes Spine Bone Mineral Density Z-scores but Not the Relationship with Prevalent Vertebral Fractures 2014
The Effect of Kidney Function on the Performance of FRAX: A Population-based report from CaMos. 2014
Use of the Safe Functional Motion-6 test to classify individuals at risk for functional decline following a distal radius fracture. 2014
Optimal Dose of Vitamin D Replacement in Middle Eastern and North African Population: a Systematic Review and Meta-analysis 2014
Vitamin D replacement in patients undergoing bariatric surgery: a systematic review and meta-analysis. 2014
"Is this exercise safe?" - Building consensus around responses to common questions about physical activity posed by people with osteoporosis 2013
A Frailty Index Predicts 10-Year Fracture Risk: Longitudinal Data from the Canadian Multicentre Osteoporosis Study (CaMos) 2013
A Randomized Controlled Trial Evaluating Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX (R) versus CAROC Reports 2013
A Successful Knowledge Translation Intervention in Long-Term Care: Results from the Vitamin D and Osteoporosis (ViDOS) Cluster Randomized Trial 2013
A new in vivo methodology for quantifying intramuscular adipose tissue (IMAT) in the lower leg of women to define the relationship with BMD, strength, physical function and lifestyle variables 2013
Associations of Protein Intake and Protein Source with Bone Biomarkers, Bone Mineral Density and Fracture Risk in a Canadian Population-based Study 2013
Bone Mineral Distribution in the Tibiae of Stroke Survivors During the First Year of Recovery: A pQCT Study 2013
Bone from Low Capacity Running Rats Exhibit Altered Mitochondrial Gene Expression Compared to High Capacity Running Rats after an Exhaustive Bout of Exercise 2013
Effect of Teriparatide on Healing of Incomplete Atypical Femur Fractures 2013
FRAX Predicts Fracture Risk in Kidney Transplant Recipients 2013
Fetal Exposure to Selective Serotonin Reuptake Inhibitors has Long-Term Adverse Effect on Bone Properties in Rats 2013
Fracture?, Think Osteoporosis: Rehabilitation of Patients Post Hip Fracture 2013
Further Reduction in the Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With Up to 7 Years in the FREEDOM Extension 2013
Higher Dairy Intakes are Associated with Improved Bone Health in a Population-based Study - CaMos 2013
International Consensus on Diagnosis and Management of Osteonecrosis of the Jaw 2013
Life-long Western Style Diet has Greater Adverse Affects on Cancellous Bone in Adult Female Wistar Rats Compared to Male Rats 2013
Magnetic Resonance Imaging (MRI)-Based Measures of Muscle Structure and Fat Infiltration in the Lower Leg of Postmenopausal Women with Osteopenia and Osteoporosis 2013
Measuring Compliance with Oral Bisphosphonates: Potential Impact of Days Supply Errors in Pharmacy Data 2013
Outcomes in Patients with Atypical Femur Fractures: the Ontario AFF Cohort 2013
Prevalence and Predictive Capacities of Different Definitions of Severe Osteoporosis 2013
The Effect of Anticholinergic Medications on Fracture Risk, Bone Mineral Density, and Falls over a Ten Year Period 2013
Uptake of Evidence-based Osteoporosis Practices in Canadian Long-term Care (LTC) 2013
Minimally invasive parathyroidectomy versus bilateral neck exploration for primary hyperparathyroidism: a systematic review and meta-analysis 2013
Advanced Vertebral Compression at Diagnosis among Children with Acute Lymphoblastic Leukemia. 2008
Attitudes to Fracture Prevention in Long-term Care Facilities: A Multicentre Study Examining the Opinions of Nursing Home Staff. 2008
BONE DESTINY - A One Step Fracture Risk Predictor for Clinicians. 2008
Comparison of 2D and 3D Subchondral Bone Texture Parameters in Severe OA Knees. 2008
Distribution of Risk Factors for Fracture in Women With and Without a Fracture History: A Regional Comparison. The Global Longitudinal Registry of Osteoporosis in Women. 2008
Efficacy of Odanacatib in the Ovariectomized Rhesus Monkey as Measured with pQCT. 2008
Family Physician Characteristics that Predict Appropriate X-ray Ordering: Canadian Quality Circle (CQC) National Project 2008
Fractures of the Spine and Hip Increase the Risk of Death in Canadians. 2008
Normative Z-scores from the Canadian Multicentre Osteoporosis Study Youth Cohort. 2008
Patients with Fragility Fracture Assessed by BNID, Bone DESTINY and Osteoporosis Canada Guidelines 2008
Predictors of Osteoporosis Management Among Residents Living in Long-Term Care 2008
Reduced Renal Function Is Associated with Increased Rates of Bone Loss At The Hip And Spine: The Canadian Multicentre Osteoporosis Study. 2008
Risk Factors for Low BMD in Healthy Men Age 50 Years or Older: A Systematic Review. 2008
Strategies for Hip Fracture Prevention in Long-term Care Facilities: A Survey of Canadian Geriatricians and Family Physicians. 2008
The 10-Year Probability of Recurrent Osteoporotic Fractures After a Primary Wrist Fracture in Postmenopausal Women Enrolled in the Canadian Multicentre Osteoporosis Study (CaMOS) 2008
The Effect of Exercise on Geometric Bone Structure and Bone Strength in Postmenopausal Women - A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2008
The Effects of Long-term Administration of High-dose Growth Hormone on Body Composition and Bone Mineralization 2008
The Efficacy of Whole-Body Vibration in Reducing Bone Loss in Postmenopausal Women: A Meta-Analysis. 2008
The Population Burden of First and Repeat Low-trauma Fractures: The Canadian Multicentre Osteoporosis Study. 2008
Treating Osteoporosis in the Elderly: An Environmental Scan of Nursing Home Prescribing in Ontario, Canada. 2008
Treatment Discontinuation Due to Gastrointestinal Adverse Events and Decreased Bone Mineral Density in Patients Switched from Branded Alendronate to Generic Alendronate. 2008
5 year incidence of fractures in patients with severe osteoporosis: The Canadian Multicentre osteoporosis study (CaMos) 2007
A five year longitudinal study of health related quality of life in individuals with and without incident fractures: The Canadian Multicentre osteoporosis study (CaMos) 2007
A meta-analysis of individual patient data: Significant reduction in non-vertebral fractures with high- versus low-dose ibandronate 2007
Associations between bone mineral density and speed of sound: Canadian Multicentre osteoporosis study 2007
Bisphosphonate use increases in patients with osteopenia and prior fractures following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) national project 2007
Bisphosphonate use increases in patients with osteoporosis following an integrated osteoporosis educational intervention: Canadian Quality Circle (CQC) National Project. 2007
Bone morbidity at diagnosis among children with acute lymphoblastic leukemia. 2007
CFOS trial: Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients 2007
Canadian normative data for sunlight omnisense quantitative ultrasound: Canadian Multicentre osteoporosis study 2007
Comparison of pQCT-based measures of radial bone geometry and apparent trabecular structure acquired using different algorithms 2007
Early and sustained non-vertebral fracture efficacy with risedronate 2007
Fragility fracture increases antidepressant use among women 65 years of age and older 2007
Identifying the treatment care gap in postmenopausal women at the southlake regional health centre: The role of a "Shared Care" model 2007
Long-term propranalol improves bone mineral content and lean body mass in pediatric burn patients. 2007
Morphometric vertebral fracture status and WHO predictors of fracture risk 2007
Nitrates and BMD among Canadian men and women 2007
Peripheral quantitative computed tomography (pQCT) reproducibility of volumetric bone density measurements at the radius and tibia in healthy women 2007
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial 2007
Trends in femur structural strength with aging in Canadian adults: 2 Canadian multicentre osteoporosis study 2007
X-ray ordering improves in patients with height loss or kyphosis following an osteoporosis educational intervention: Canadian Quality Circle (CQC) national project 2007
Alendronate in primary hyperparathyroidism: Efficacy in men and premenopausal women. 2006
Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients. 2006
Carboxyl-terminal fragments of PTH inhibit rPTH(1-34) induced 1,25(OH)(2) vitamin D synthesis and renal CYP28B1 mRNA expression in parathyroidectornized rats. 2006
Effectiveness of bone mineral density for predicting osteoporotic fractures in a large clinical population. 2006
Fracture risk and site-discordance: The total hip dominates other sites. 2006
Greater number of osteoporotic sites and fracture risk: Regression to the minimum. 2006
Importance of the calcium/phosphorus ratio in the growth plate normalisation during vitamin D and calcium repletion in the rat. 2006
It could happen to me: Perceptions of future fracture risk in individuals with a history of fragility fracture. 2006
Low BMD is associated with fractures in patients with renal failure: A meta-analysis. 2006
Prognostic factors for first clinical fracture in patients with primary osteoporosis: Data from the Canadian database of osteoporosis and osteopenia (CANDOO). 2006
The association among risk factors for fracture and family physicians' beliefs that their patients are at high risk for a future fracture: Canadian quality circle (CQC) national project. 2006
The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women. 2006
The rate that family physicians prescribe calcium and Vitamin D to their patients with fractures following an educational intervention: Canadian Quality Circle (CQC) national project. 2006
The relationship among key risk factors for fracture and family physicians' beliefs that their patients have osteoporosis: Canadian quality circle (CQC) National Project. 2006
A meta-analysis of hip protector trials in institutionalized elderly using a Bayesian approach. 2005
Barriers and facilitators to osteoporosis medication adherence: Patient perceptions and strategies. 2005
Family physicians' awareness of key osteoporosis risk factors and the utilization of bone mineral density (BMD) testing following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project. 2005
Knowledge dissemination strategies translate into improved post-fracture osteoporosis care 2005
Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre osteoporosis study (CaMOS). 2005
Risedronate demonstrates antifracture efficacy over a range of baseline BMD levels. 2005
The economic implications of a policy of provision of hip protectors to institutionalized elderly in Ontario, Canada. 2005
The evaluation of process factors involved in performing the Canadian Quality Circle (CQC) Pilot Project for the care of patients at risk for osteoporosis. 2005
The rate that family physicians prescribe osteoporosis medications to their patients: Canadian Quality Circles (CQC) Project. 2005
Treatment-related changes in BMD are not associated with the occurrence of a fragility fracture while on risedronate therapy 2005
A multi-faceted post-fracture care model: The fracture? Think osteoporosis! Program. 2004
Detection of prevalent vertebral fractures using historical height loss: Comparison of different height measurement methods. 2004
Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. 2004
Family physician awareness of risk factors for fracture and the appropriate use of bone mineral density screening in accordance with the Canadian osteoporosis guidelines: Canadian Quality Circles (CQC) Project. 2004
Health Utilities Index 3 scores in osteoporosis compared to other chronic medical conditions: A population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). 2004
High prevalence of fracture in young adults with cystic fibrosis. 2004
Impact of non-compliance and non-persistence with daily Bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis. 2004
Study design of the Canadian quality circle (CQC) pilot project in osteoporosis 2004
The number of Canadian men and women needed to be screened to detect a case of osteoporosis: A population-based study from the Canadian Multicentre osteoporosis study (CaMos) 2004
The rate that family physicians prescribe pharmacological treatment to their patients: Canadian quality circles (CQC) project. 2004
The relation of medial minimum joint space width to age in the knees of healthy and osteoarthritic women. 2004
Vitamin D insufficiency is highly prevalent among North American women treated for osteoporosis. 2004
PSA protein and activity in prostate cancer and human bone-metastasizing Prostate Cancer LNCaP cells 2004
Survival-adjusted multiple event analysis of skeletal complications front bone metastases: A comprehensive analysis of treatment benefit 2004
The predictive value of bone resorption and formation markers in patients with prostate cancer metastatic to bone 2004
The prognostic significance of biochemical markers of bone metabolism in patients with bone metastases from solid tumors other than breast and prostate cancer 2004
Treatment of bone metastasis with a combination of doxycycline and zoledronate 2004
A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism. 2003
Body weight supported treadmill training in individuals with incomplete spinal cord injury: Effects on bone mass and body composition. 2003
Both oral and intravenous ibandronate effectively prevent postmenopausal bone loss in women without osteoporosis. 2003
Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis. 2003
Men present with a higher rate of prevalent fractures than women when started on bisphosphonate therapy in Canadian specialty osteoporosis practices. 2003
Participant characteristics that predict new clinically recognized vertebral fracture in postmenopausal women: The Canadian Multicentre Osteoporosis Study (CaMos). 2003
Predicting previous fracture with the health utilities index (HUI) mark II and III systems in both women and men: The Canadian Multicentre osteoporosis study (CaMos). 2003
Risk factors related with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: The Canadian Database of Osteoporosis and Osteopenia (CANDOO). 2003
Risk factors that predict new non-vertebral fracture in postmenopausal women: The Canadian Multicentre Osteoporosis Study (CaMos). 2003
The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women. 2003
The human cost of fractures in community dwelling older adults. 2003
The relations between lumbar spine, hip, distal femur and proximal tibia bone mineral density in healthy individuals. 2003
The relations between minimum joint space width in the knee and bone mineral density in the spine, hip, distal femur and proximal tibia. 2003
Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross-Sectional Results From the Canadian Multicentre Osteoporosis Study 2003
A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism. 2002
Adherence profile of etidronate (ETD), alendronate (ALD) and hormone replacement therapy (HRT) in patients registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO). 2002
Bone mineral density at the hip and tibia and speed of sound at the tibia in spinal cord injured individuals. 2002
CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up 2002
Calcitriol regulates the expression of genes encoding all three vitamin D3-hydroxylases in the human fetal intestine. 2002
Prevalence and severity of vertebral fractures among patients with chronic obstructive pulmonary disease (COPD) in Canada. 2002
Relation between disease activity and apparent trabecular texture at the wrist in individuals with rheumatoid arthritis. 2002
Risedronate conserves periarticular bone and ligament mechanical properties in early osteoarthritis. 2002
Secondary causes of osteoporosis in patients registered in the Canadian database of osteoporosis and osteopenia (CANDOO). 2002
The impact of dropouts on the efficacy of 5 mg risedronate: An assessment based on an imputation analysis 2002
The influence of bone mineral density (BMD) testing on the treatment of osteoporosis (OP) in two Canadian non-academic community centres. 2002
The relationship between prospective height loss and multiple vertebral fractures. 2002
The utility of prospective height loss for detecting vertebral fracture depends on fracture incidence 2002
A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism. 2001
Development and evaluation of a decision aid for women with established osteoporosis. 2001
Lengthy hospitalizations associated with vertebral fractures despite control for comorbid conditions. 2001
Modifying proteins for an increased bone affinity. 2001
New England Registry for Paget's disease of bone. 2001
PTH treatment directly stimulates bone formation in cancellous and cortical bone in humans. 2001
Prevalence of vertebral fracture among patients with Chronic Obstructive Pulmonary Disease (COPD) in Canada. 2001
Significance of vertebral deformity as indicated by the SF-36 quality of life measures. 2001
The cost-effectiveness of calcium and vitamin D or hormone replacement therapy versus no intervention in the prevention of hip fractures in Canadian postmenopausal women. 2001
The impact of co-morbid conditions on bone mineral density and vertebral deformities in community dwelling men and women across Canada. 2001
The impact of osteoporotic fractures on health related quality of life (HRQL) as measured by the health utilities index. 2001
The impact of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients. 2001
Twelve month efficacy of home-based exercise for improving the quality of life of elderly women with symptomatic osteoporosis related vertebral fractures. 2001
Validity of patient-reported diagnoses of osteoarthritis and rheumatoid arthritis: Results from the Canadian Multicenter Osteoporosis Study (CaMOS). 2001
Assessment of apparent trabecular bone porosity at the distal radius in women matched for bone density discriminates individuals with recent wrist fractures from those without fracture. 2000
Bone geometry and biomechanical indices in children and adolescents with insulin-dependent diabetes mellitus (IDDM): Influence of exercise. 2000
Canadian male normative speed of sound (SOS) database for the sunlight omnisense bone sonometer. 2000
Corticosteroid-mediated changes in bone mineral metabolism in children treated for acute lymphoblastic leukemia. 2000
Effect of vitamin D on patients with osteoporosis not responding to stable bisphosphonate therapy. 2000
Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: a prospective observational study. 2000
Effects of pamidronate infusion to reverse observed abnormalities in bone metabolism and mineral mass in children during chemotherapy for acute lymphoblastic leukemia. 2000
Efficacy of home-based exercise for improving the physical functioning of elderly women with symptomatic osteoporosis-related vertebral fractures. 2000
Feeding preterm infants mother's milk compared to standard formula influences bone mass accretion and growth to one year corrected age. 2000
Hypomagnesemia associated with chemotherapy in children treated for primary acute lymphoblastic leukemia: Possible mechanisms. 2000
Intervention with growth hormone and enriched diet during and/or after dexamethasone treatment does not attenuate dexamethasone-induced growth restriction and low bone mass in piglets. 2000
Non-vertebral fractures and quality of life. 2000
Patient adherence to bisphosphonate therapy. 2000
Re-fracture one year following hip fracture in Canada. 2000
Risedronate has significantly lower incidence of gastric ulcers compared to alendronate. 2000
Risk factors associated with osteoporosis in developmentally disabled adults. 2000
Stimulation of osteoclast differentiation in vitro by mouse Oncostatin M, leukemia inhibitory factor, cardiotrophin-1 and interleukin-6: Synergy with dexamethasone. 2000
Vertebral fractures and quality of life. 2000
Epileptic children treated with valproate and lamotrigine may be at risk for reduced growth and bone mineralization. 1999
How were patients with BMD results managed by their primary care physicians from 1992 to 1995. 1999
Impact of first-time bone mineral density testing on osteoporosis-related treatment patterns in 2 non-academic settings. 1999
In vivo distal radius bone structure measurements. 1999
Influence of the calcium and vitamin D status on Ca2+ signaling, the state of the IP3-sensitive Ca2+ pools, and endoplasmic reticulum calcium binding proteins. 1999
Longer stay when vertebral fractures co-exist with other health problems necessitating hospitalization. 1999
The influence of osteoporotic fractures on health related quality of life (HRQL) in community dwelling men and women across Canada. 1999
The relationship between fracture and other variables in the Hamilton subset of the Canadian Multicentre Osteoporosis Study dataset determined through a pattern discovery algorithm. 1999
An open-label, multicentre trial on intermittent cyclical therapy with etidronate in postmenopausal osteoporotic women. 1997
Bone mass and structure measurements by DXA, pQCT and ultrasound at the hip, spine, radius and heel in women who are osteoporotic or osteopenic 1997
Bone turnover markers predict changes in bone mineral density in patients treated with corticosteroids. 1997
Comparison of BMD measurements at 6 and 12 months in assessing response to etidronate in osteoporosis 1997
Effects of education on decisions to start hormone therapy by postmenopausal women at risk for fractures. 1997
Etidronate therapy in patients on high dose corticosteroids: Differences in bone resorption marker responses. 1997
Fluoride therapy in the prevention of rheumatoid arthritis induced bone loss. 1997
How commonly do physicians attribute: Hip fractures to osteoporosis in acute care? 1997
Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up 1997
Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo. 1997
Intermittent cyclical therapy with etidronate prevents bone loss in corticosteroid treated patients and reduces fracture rate in a subgroup of postmenopausal women. 1997
Peripheral quantitative computed tomography measurements of normal human bone mass and structure. 1997
Risedronate treatment improves pain status in patients with Pagets disease of bone 1997
Risedronate vs. etidronate Pagets study: Durable remission with only two months of 30 mg risedronate 1997
The steady state expression of the gene encoding the hepatic mitochondrial vitamin D-3 25-hydroxylase (CYP27) is not regulated by the vitamin D or calcium status. 1997
Where do Canadian hip fracture patients go one year post discharge from acute care hospitals, and what is the cost of their follow-up care? 1997
Assessment of antibody formation in patients with osteoporosis treated with cyclical hPTH 1-34 and salmon calcitonin. 1996
Comparison of etidronate and estrogen: Effects on lumbar spinal bone mineral density change and vertebral fracture rate. 1996
Cyclical parathyroid hormone with or without sequential calcitonin or treat osteoporosis: Final results of a 2 year clinical trial 1996
In vivo assessment of trabecular bone structure 1996
What is the yield of screening for secondary causes of osteoporosis? 1996
EVALUATION OF A NEW OSTEOPOROSIS QUALITY-OF-LIFE QUESTIONNAIRE (OQLQ) FOR WOMEN WITH OSTEOPOROSIS AND BACK PAIN 1995
IN-VIVO ASSESSMENT OF TRABECULAR BONE-STRUCTURE 1995
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP 1995
WILLINGNESS TO INITIATE HORMONE REPLACEMENT THERAPY FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS - IDENTIFICATION OF PATIENT SUBSETS 1995
CHRONIC DEXAMETHASONE (DEX) TREATMENT IMPAIRS CALCIUM-ABSORPTION AND BONE MINERALIZATION IN INFANT PIGS 1993
INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS 1993
PREDICTORS OF OSTEOPENIA AND FRACTURES IN CHILDREN DURING TREATMENT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA 1993
THE NORMAL SKELETAL LEAD BURDEN 1993
CHRONIC HYPOCALCEMIA OF VITAMIN-D DEPLETION PERTURBS HEPATIC INTRACELLULAR CALCIUM-CONCENTRATION, AND EGF RECEPTOR DENSITY AND RESPONSE 1992
NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS 1992
OSTEOPOROSIS IN MEN - PREVALENCE AND BIOCHEMICAL PARAMETERS 1992
A systematic review and meta-analysis of the effects of probiotics on bone outcomes in rodent models.. zjae187. 2024
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.. 39:1493-1502. 2024
Sedentary behavior does not predict low BMD nor fracture—population-based Canadian Multicentre Osteoporosis Study. 39:231-240. 2024
Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy. 38:1104-1115. 2023
Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study. 36:2106-2115. 2021
A Risk Assessment Tool for Predicting Fragility Fractures and Mortality in the Elderly. 35:1923-1934. 2020
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. 36:2290-2299. 2020
Bone Marrow and Muscle Fat Infiltration Are Correlated among Postmenopausal Women With Osteoporosis: The AMBERS Cohort Study. 35:516-527. 2020
Combining Frailty and Trabecular Bone Score Did Not Improve Predictive Accuracy in Risk of Major Osteoporotic Fractures. 35:1058-1064. 2020
Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review. 37:2642-2653. 2020
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. 38:14-25. 2020
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. 37:2568-2585. 2020
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. 37:2293-2314. 2020
Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study. 38:650-658. 2020
Hypoparathyroidism: Genetics and Diagnosis. 37:2615-2629. 2020
Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey. 37:2630-2641. 2020
Lipopolysaccharide-Induced Bone Loss in Rodent Models: A Systematic Review and Meta-Analysis. 38:198-213. 2020
Management of Hypoparathyroidism. 37:2663-2677. 2020
Management of Primary Hyperparathyroidism. 37:2391-2403. 2020
Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism. 37:2404-2410. 2020
Parathyroid Hormone Therapy for Managing Chronic Hypoparathyroidism: A Systematic Review and Meta-Analysis. 37:2654-2662. 2020
Relationship Between Obesity and Risk of Major Osteoporotic Fracture in Postmenopausal Women: Taking Frailty Into Consideration. 35:2355-2362. 2020
Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect. 37:1075-1076. 2020
Subcanalicular Nanochannel Volume Is Inversely Correlated With Calcium Content in Human Cortical Bone. 38:313-325. 2020
The Accuracy of Incident Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches. 36:1255-1268. 2020
The Accuracy of Prevalent Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches. 35:460-468. 2020
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial. 37:2435-2442. 2020
The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 37:2351-2372. 2020
The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism. 37:2290-2292. 2020
The Second International Workshop on the Evaluation and Management of Hypoparathyroidism. 37:2566-2567. 2020
Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis. 34:2001-2011. 2019
Incident Fragility Fractures Have a Long-Term Negative Impact on Health-Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study. 34:838-848. 2019
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study. 34:419-428. 2019
Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study. 33:1435-1443. 2018
Vertebral Fractures and Morphometric Deformities. 33:1544-1545. 2018
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. 33:1219-1226. 2018
Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype. 33:1260-1271. 2018
Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos). 33:569-579. 2018
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses. 33:419-429. 2018
Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality. 32:1802-1810. 2017
Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women. 31:1466-1472. 2016
Histomorphometry and Bone Matrix Mineralization Before and After Bisphosphonate Treatment in Boys With Duchenne Muscular Dystrophy: A Paired Transiliac Biopsy Study. 31:1060-1069. 2016
Frailty Change and Major Osteoporotic Fracture in the Elderly: Data from the Global Longitudinal Study of Osteoporosis in Women 3-Year Hamilton Cohort. 31:718-724. 2016
Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”. 30:1941-1941. 2015
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders. 30:1667-1675. 2015
Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”. 30:1116-1117. 2015
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus. 30:3-23. 2015
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture. 29:2545-2551. 2014
Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW). 29:487-493. 2014
Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW). 29:260-267. 2014
Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: The Canadian Multicentre Osteoporosis Study. 28:2027-2034. 2013
Trends in hip fracture rates in Canada: An age-period-cohort analysis. 28:1283-1289. 2013
Transcriptomic and proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis. 27:1976-1991. 2012
The burden of illness of osteoporosis in Canadian men. 27:1830-1838. 2012
Denosumab treatment for fibrous dysplasia. 27:1462-1470. 2012
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. 27:1381-1389. 2012
Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women. 27:645-653. 2012
Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. 27:202-210. 2012
Predicting fractures in an international cohort using risk factor algorithms without BMD. 26:2770-2777. 2011
Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. 26:2317-2337. 2011
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study. 25:2239-2250. 2010
Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. 25:1948-1957. 2010
Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. 25:1077-1091. 2010
Repeat Low-Trauma Fractures Occur Frequently Among Men and Women Who Have Osteopenic BMD. 24:1515-1522. 2009
Advanced Vertebral Fracture Among Newly Diagnosed Children With Acute Lymphoblastic Leukemia: Results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Research Program. 24:1326-1334. 2009
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture. 24:1308-1313. 2009
Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk. 24:495-502. 2009
Association Between Change in BMD and Fragility Fracture in Women and Men. 24:361-370. 2009
Subpixel Enhancement of Nonuniform Tissue (SPENT): A Novel MRI Technique for Quantifying BMD. 24:324-333. 2009
Bridging the Osteoporosis Quality Chasm. 24:3-7. 2009
Changes to Osteoporosis Prevalence According to Method of Risk Assessment. 22:228-234. 2007
Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?. 20:898-905. 2005
Analysis of Environmental Factors in Familial Versus Sporadic Paget's Disease of Bone—The New England Registry for Paget's Disease of Bone. 18:1519-1524. 2003
Measurement of Midfemoral Shaft Geometry: Repeatability and Accuracy Using Magnetic Resonance Imaging and Dual-Energy X-ray Absorptiometry. 16:2251-2259. 2001
A Randomized Controlled Trial of Vitamin D Supplementation on Preventing Postmenopausal Bone Loss and Modifying Bone Metabolism Using Identical Twin Pairs. 15:2276-2283. 2000
Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. 11:1774-1783. 1996
Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: Response to calcium, vitamin D3 and calcitriol administration in vivo. 10:1148-1157. 1995
Establishment of the primary structure of the major lipid-dependent Ca2+ binding proteins of chicken growth plate cartilage matrix vesicles: Identity with anchorin cii (annexin V) and annexin II. 7:807-819. 1992
Aluminum intoxication in vitamin D-deficient rats: Studies of bone aluminum localization and histomorphometry before and after vitamin D repletion. 3:375-384. 1988
Microvascular organization at the epiphyseal-metaphyseal junction of growing rats. 2:143-149. 1987

Journal of Bone and Mineral Research Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)